BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24456076)

  • 21. The adaptor protein NTAL enhances proximal signaling and potentiates corticosteroid-induced apoptosis in T-ALL.
    Svojgr K; Kalina T; Kanderova V; Skopcova T; Brdicka T; Zuna J
    Exp Hematol; 2012 May; 40(5):379-85. PubMed ID: 22269118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
    Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HDAC inhibitors induce apoptosis in glucocorticoid-resistant acute lymphatic leukemia cells despite a switch from the extrinsic to the intrinsic death pathway.
    Tsapis M; Lieb M; Manzo F; Shankaranarayanan P; Herbrecht R; Lutz P; Gronemeyer H
    Int J Biochem Cell Biol; 2007; 39(7-8):1500-9. PubMed ID: 17499001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukaemia.
    Meyer LK; Delgado-Martin C; Sharp PP; Huang BJ; McMinn D; Vincent TL; Ryan T; Horton TM; Wood BL; Teachey DT; Taunton J; Kirk CJ; Hermiston ML
    Br J Haematol; 2022 Jul; 198(1):137-141. PubMed ID: 35434798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered expression of autophagy-related genes might contribute to glucocorticoid resistance in precursor B-cell-type acute lymphoblastic leukemia.
    Sarang Z; Gyurina K; Scholtz B; Kiss C; Szegedi I
    Eur J Haematol; 2016 Nov; 97(5):453-460. PubMed ID: 26947147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways.
    Lv M; Zhang X; Jia H; Li D; Zhang B; Zhang H; Hong M; Jiang T; Jiang Q; Lu J; Huang X; Huang B
    Leukemia; 2012 Apr; 26(4):769-77. PubMed ID: 21979877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylprednisolone potentiates tetrandrine pharmacodynamics against human T lymphoblastoid leukemia MOLT-4 cells via regulation of NF-κB activation and cell cycle transition.
    Xu W; Chen S; Wang X; Wu H; Yamada H; Hirano T
    Steroids; 2020 Nov; 163():108714. PubMed ID: 32818521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia.
    Chiarini F; Grimaldi C; Ricci F; Tazzari PL; Evangelisti C; Ognibene A; Battistelli M; Falcieri E; Melchionda F; Pession A; Pagliaro P; McCubrey JA; Martelli AM
    Cancer Res; 2010 Oct; 70(20):8097-107. PubMed ID: 20876803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway.
    Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
    Biochem Biophys Res Commun; 2008 Sep; 374(2):309-14. PubMed ID: 18625202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation.
    Suganuma K; Miwa H; Imai N; Shikami M; Gotou M; Goto M; Mizuno S; Takahashi M; Yamamoto H; Hiramatsu A; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
    Leuk Lymphoma; 2010 Nov; 51(11):2112-9. PubMed ID: 20860495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inducing apoptosis in chemotherapy-resistant B-lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti-apoptotic unfolded protein response signalling network.
    Uckun FM; Qazi S; Ozer Z; Garner AL; Pitt J; Ma H; Janda KD
    Br J Haematol; 2011 Jun; 153(6):741-52. PubMed ID: 21517817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivative.
    Ganguly A; Banerjee K; Chakraborty P; Das S; Sarkar A; Hazra A; Banerjee M; Maity A; Chatterjee M; Mondal NB; Choudhuri SK
    Biomed Pharmacother; 2011 Sep; 65(6):387-94. PubMed ID: 21715129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.
    Kaspers GJ; Wijnands JJ; Hartmann R; Huismans L; Loonen AH; Stackelberg A; Henze G; Pieters R; Hählen K; Van Wering ER; Veerman AJ
    Eur J Cancer; 2005 Jun; 41(9):1300-3. PubMed ID: 15869873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NFkappaB modulators in a model of glucocorticoid resistant, childhood acute lymphoblastic leukemia.
    Nicholson L; Hall AG; Redfern CP; Irving J
    Leuk Res; 2010 Oct; 34(10):1366-73. PubMed ID: 20106524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrocortisone does not influence glucocorticoid sensitivity of acute lymphoblastic leukemia cells.
    Warris LT; van den Heuvel-Eibrink MM; Ariës IM; Pieters R; van den Akker EL; den Boer ML
    Haematologica; 2015 Apr; 100(4):e137-9. PubMed ID: 25425687
    [No Abstract]   [Full Text] [Related]  

  • 36. Circumvention of glucocorticoid resistance in childhood leukemia.
    Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ
    Leuk Res; 2008 Sep; 32(9):1417-23. PubMed ID: 18395253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of heat-shock protein 90 in glucocorticoid-sensitive and -resistant childhood acute lymphoblastic leukaemia.
    Lauten M; Beger C; Gerdes K; Asgedom G; Kardinal C; Welte K; Schrappe M
    Leukemia; 2003 Aug; 17(8):1551-6. PubMed ID: 12886242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response.
    Shepherd C; Banerjee L; Cheung CW; Mansour MR; Jenkinson S; Gale RE; Khwaja A
    Leukemia; 2013 Mar; 27(3):650-60. PubMed ID: 23038273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential ex vivo activity of bortezomib in newly diagnosed paediatric acute lymphoblastic and myeloblastic leukaemia.
    Szczepanek J; Pogorzala M; Konatkowska B; Juraszewska E; Badowska W; Olejnik I; Kuzmicz M; Stanczak E; Malinowska I; Stefaniak J; Sobol G; Szczepanski T; Czyzewski K; Wysocki M; Styczynski J
    Anticancer Res; 2010 Jun; 30(6):2119-24. PubMed ID: 20651360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells.
    Wang J; Liu X; Qiu Y; Shi Y; Cai J; Wang B; Wei X; Ke Q; Sui X; Wang Y; Huang Y; Li H; Wang T; Lin R; Liu Q; Xiang AP
    J Hematol Oncol; 2018 Jan; 11(1):11. PubMed ID: 29357914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.